在多发性硬化症护理中的COVID-19时代
Jonathan D Krett1, Amber Salter2, Scott D Newsome1
1Division of Neuroimmunology and Neurological Infections, Department of Neurology, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Pathology 627, Baltimore, MD 21287, USA.
COVID-19大流行扰乱了多发性硬化症 (MS) 护理,导致远程医疗和新的安全协议等创新. 在患有多发性硬化症 (PwMS) 患者中了解COVID-19风险的发展,指导治疗和疫苗推.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 由于COVID-19大流行,全球医疗保健服务发生了重大干扰.
- 多发性硬化症 (PwMS) 患者在疫情期间在获得护理方面面临着独特的挑战.
- 现有的多发性硬化症 (MS) 护理模式需要调整,以确保患者的安全和治疗的连续性.
研究的目的:
- 审查COVID-19大流行对多发性硬化症 (MS) 护理的影响.
- 突出流行病引起的MS护理方面的创新,例如远程医疗.
- 讨论PwMS对COVID-19风险和管理策略的不断变化的理解.
主要方法:
- 在COVID-19大流行期间对MS护理的研究和报告的文献综述.
- 对PwMS的医疗保健提供模式变化的分析.
- 在PwMS中综合了疾病修饰疗法和疫苗的最新建议.
主要成果:
- 疫情加快了在MS护理中采用远程医疗和远程患者监测的速度.
- 全球MS社区迅速实施了新的安全协议来保护PwMS.
- 关于COVID-19对PwMS的影响以及疫苗和疗法的有效性/安全性的知识有了显著的进步.
结论:
- 随着COVID-19大流行,多发性硬化症 (MS) 护理的创新和适应成为了催化剂.
- 远程医疗和灵活的护理模式很可能仍然是MS管理的组成部分.
- 未来的研究应该解决大流行对PwMS的长期影响,并完善护理策略.
更多相关视频
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
相关概念视频
Cardiomyopathy V: Interprofessional Care
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Myocarditis IV: Nursing Management
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Acute Coronary Syndrome IV: Interprofessional Care
